New insights into development and mortality of COVID-19-associated pulmonary aspergillosis in a homogenous cohort of 1161 intensive care patientsArticle Published on 2022-11-012022-11-15 Journal: Mycoses [Category] [DOI] 10.1111/myc.13485 PMC 바로가기
Microvascular and proteomic signatures overlap in COVID-19 and bacterial sepsis: the MICROCODE studyArticle Published on 2022-11-012022-11-15 Journal: Angiogenesis [Category] [DOI] 10.1007/s10456-022-09843-8 PMC 바로가기
Advances in Biosensing Technologies for Diagnosis of COVID-19Article Published on 2022-10-202022-11-15 Journal: Biosensors [Category] [DOI] 10.3390/bios12100898 PMC 바로가기
Observational study of factors associated with morbidity and mortality from COVID-19 in Lebanon, 2020-2021Article Published on 2022-10-192022-11-15 Journal: PLoS ONE [Category] [DOI] 10.1371/journal.pone.0275101 PMC 바로가기
Small-Molecule RAF265 as an Antiviral Therapy Acts against PEDV InfectionArticle Published on 2022-10-152022-11-15 Journal: Viruses [Category] [DOI] 10.3390/v14102261 PMC 바로가기
Characterization of serotonin as a candidate biomarker of severity and prognosis of COVID-19 using LC/MS analysisResearch article Published on 2022-10-012022-10-05 Journal: Journal of pharmacological sciences [Category] [DOI] 10.1016/j.jphs.2022.06.005 [Article Type] Research article
Lactate dehydrogenase/albumin ratio as a prognostic factor in severe acute respiratory distress syndrome cases associated with COVID-19Article Published on 2022-09-232022-11-15 Journal: Medicine [Category] [DOI] 10.1097/MD.0000000000030759 PMC 바로가기
Single-Cell Gene Expression Analysis Revealed Immune Cell Signatures of Delta COVID-19Article Published on 2022-09-212022-11-16 Journal: Cells [Category] [DOI] 10.3390/cells11192950 PMC 바로가기
Acute kidney injury in critically ill COVID-19 infected patients requiring dialysis: experience from India and PakistanArticle Published on 2022-09-082022-11-16 Journal: BMC Nephrology [Category] [DOI] 10.1186/s12882-022-02931-3 PMC 바로가기
Infliximab in the treatment of patients with severe COVID-19 (INFLIXCOVID): protocol for a randomised, controlled, multicentre, open-label phase II clinical studyArticle Published on 2022-09-022022-10-04 Journal: Trials [Category] [DOI] 10.1186/s13063-022-06566-5 PMC 바로가기 [Article Type] Article